Malignant tumors remain a major health burden throughout the world and new strategies are urgently needed to treat them effectively. Cancer nanotechnology has the potential to dramatically improve current approaches to cancer detection, diagnosis, imaging, and therapy while reducing toxicity associated with traditional cancer therapy. The application of nanotechnology to developing safer and more effective antitumor nanomedicine have so far proven to be both evolutionary and revolutionary and will eventually revolutionize the current landscape of cancer therapy.

The multidisciplinary nature of nanomedicine requires integration of cancer biology, clinical oncology, chemistry, physics, materials science, biomedical engineering, toxicology, computer science, and mathematics to achieve the vital goals of nanotechnology-mediated early cancer detection and more efficacious and less toxic therapies for cancer. In this course, the fundamental sciences related to cancer nanotechnology in both cancer biology and Nanoscience and technology will be covered. The issues related to preclinical and clinical applications of nanotechnology for cancer diagnosis and therapy will also be discussed. Some key methodological approaches in cancer nanotechnology and subject will also be outlined. This course will be helpful for graduate students to get an overall picture about the current landscape of nanotechnology integrated into the current tumor biology and clinical oncology.